Mindfulness for Chronic Kidney Disease

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study tests a digital mindfulness app called Calm Health among adults with chronic kidney disease (CKD). Participants will use the app for 6 weeks while wearing a wrist sensor that tracks sleep, physical activity, heart rate, and other health signals. The study will measure how acceptable and feasible the app is, and whether it may improve stress, anxiety, and quality of life. Participants will also receive health coaching and a personalized report showing how their mindfulness practice relates to their health data.

Who Is on the Research Team?

GI

Garrett I Ash, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 80 years old.
I have had chronic kidney disease for at least 6 months and saw a kidney doctor twice this year.
* Receiving CKD care at Yale Medicine Nephrology or Yale New Haven Hospital
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Calm Health app for mindfulness practice and wear a wrist sensor for 6 weeks

6 weeks
All visits conducted via televideo (Zoom)

Health Coaching

Two structured health coaching check-ins at Week 1 and Week 4

6 weeks
2 televideo visits

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Calm Health

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+